% | $
Quotes you view appear here for quick access.

Momenta Pharmaceuticals Inc. Message Board

  • t57776 t57776 Jul 2, 2012 10:32 AM Flag

    we could be next/soon

    Bristol-Myers Squibb Co.’s $5.3 billion deal to buy diabetes drugmaker Amylin Pharmaceuticals Inc. (AMLN) gives Bristol (BMY) immediate access to a market of growing medical need, while heralding a burgeoning hunger among pharmaceutical companies for acquisitions. ....Bloomberg

11.26+0.13(+1.17%)4:00 PMEDT